(Nebraska Examiner) The University of Nebraska Medical Center is among more than 60 sites nationally that has been tapped for a trial study of a monkeypox treatment. The STOMP (Study of Tecovirimat for Human Monkeypox Virus) is a phase 3 trial evaluating the safety and effectiveness of the antiviral tecovirimat drug.
Home
—
Global Center for Health Security
—
The Transmission
—
UNMC tapped for trial of monkeypox treatment
UNMC tapped for trial of monkeypox treatment
- Published Nov 1, 2022